BioCentury
ARTICLE | Company News

Oscient infectious, metabolic news

February 16, 2009 8:00 AM UTC

Oscient will restructure its commercial operations, reduce headcount by 100 (32%) to 205 and will not fill 25 vacant positions to preserve capital. The majority of the cuts will be in sales. Oscient a...